Responsible Research and Innovation (RRI): A Path Towards Sustainability?
Roger Strand, University of Bergen, Centre for the Study of the Sciences and the Humanities, Norway
Sunday, 13 May 2018 (opening ceremony) – 6:00 p.m. , Auditorium
Roger Strand is Professor at the Centre for the Study of the Sciences and Humanities and the Centre for Cancer Biomarkers at the University of Bergen, Norway, and Adjunct Professor at Department of Biotechnology and Food Science, the Norwegian University of Science and Technology, Trondheim, Norway. Originally trained as a natural scientist (PhD, biochemistry 1998), Strand developed research interests in the philosophy of science and has worked on issues of scientific uncertainty and complexity, including the theory of post-normal science. This has gradually led his research into broader strands of social research, philosophy and broader issues of policy, decision-making and governance at the science-society interface. He has coordinated two EU FP7 projects (TECHNOLIFE and EPINET), which both addressed the need for more dynamic governance of science in society. He was a member of the National Research Ethics Committee for Science and Technology in Norway (2006-2013) and Chair of the European Commission Expert Group on Indicators for Responsible Research and Innovation (2014-2015). He is one of the Directors of the European Centre for Governance in Complexity.
Dr. Bernhard Url, EFSA
Monday, 14 May 2018 – 4:15 p.m., Session Room A+B
Dr. Bernhard Url was appointed Executive Director of EFSA in June 2014, having served as Acting Executive Director for seven months. Dr. Url joined EFSA in June 2012 as Head of the Risk Assessment and Scientific Assistance Department. A qualified veterinarian by training, he brings high-level management experience from food-safety organisations to his role at EFSA.
Prior to joining the Authority, Dr. Url was Managing Director of the Austrian Agency for Health and Food Safety (AGES), which represents Austria on EFSA’s Advisory Forum. From 2008 to March 2012, he also served as a member of EFSA’s Management Board.
During his 10 years at AGES, he was in charge of technical and scientific affairs with a remit that included the timely delivery of risk assessment and risk management services across a wide range of areas. This included ensuring effective risk communications during urgent food safety-related events.
Prior to AGES Dr. Url spent five years as an Assistant Professor at the Institute of Milk Hygiene and Milk Technology at the University of Veterinary Medicine in Vienna before running a food quality control laboratory from 1993 to 2002.
Dr. Url graduated from the University of Veterinary Medicine in Vienna in 1987 and became a Doctor of Veterinary Medicine in 1990. He has published in the field of veterinary medicine with a particular focus on listeria and milk hygiene.
Innovative Research Issues in Environmental Mutagenesis
Eugenia Dogliotti, Istituto Superiore di Sanità, Department of Environment and Health, Italy
Tuesday, 15 May 2018 – 4:15 p.m., Session Room A+B
Dr. Eugenia Dogliotti is the Director of the Department of Environment and Health at Istituto Superiore di Sanità (National Institute of Health, ISS), the leading technical-scientific body of the Italian National Health Service. She graduated in Biology from the University of Rome. She was then trained in the field of molecular mutagenesis and DNA repair first at the Medical Biological Laboratory, TNO, Rijswijk (The Netherlands) and then at the Department of Applied and Biological Sciences, Massachusetts Institute of Technology (USA) where she was involved in pioneering work on the characterization of DNA damage and single-lesion mutagenesis in mammalian cells. As group leader at ISS she introduced the use of lesion-containing vectors to analyse DNA repair mechanisms achieving with her group the discovery of a new DNA repair pathway, the long-patch base excision repair. Because of these achievements, in 2015 she received the Frits Sobels Award that recognizes outstanding contributions to the field of environmental mutagenesis.
She has been President of the Italian Society of Environmental Mutagenesis (2004-2007) and of the European Environmental Mutagen Society (2007-2009). She is currently member of the Scientific Council of the International Agency for Research on Cancer (2016-2019).
Her major fields of research are the mechanisms of chemical mutagenesis and gene-environment interaction studies in human populations. She is the author of more than 140 papers in peer-reviewed international journals and books in the field of mammalian cell mutagenesis, DNA repair and genetic toxicology. She has extensive experience in risk assessment serving in national and international advisory boards.
The Environmental Dimension of Antimicrobial Resistance: Assessing and Managing the Risks of Anti-infectives.
Jason Snape, AstraZeneca Global Safety, Health and Environment, United Kingdom
Wednesday, 16 May 2018 – 4:15 p.m., Session Room A+B
Jason Snape is the Senior Principal Environmental Scientist within AstraZeneca and is the Director of their Safety, Health and Environment (SHE) Research and Foresight programmes. Jason is an environmental microbiologist, biochemist and environmental risk assessor who provides scientific leadership on the pharmaceuticals in the environment (PIE) issue for AstraZeneca and helps support the wider Pharmaceutical Industry. Jason’s specific expertise and research is focused on (i) the environmental risk assessment of human medicinal products, (ii) the biodegradation and persistence of chemicals in the environment, (iii) determining the significance of antimicrobial resistance (AMR) in the environment as a source of resistance for clinical infection and the development of appropriate regulatory frameworks and guidance to improve environmental risk assessment for anti-infectives, and (iv) assessing the risks posed by medicinal products in emerging markets where use and exposure patterns differ due to the absence of adequate waste and drinking water treatment infrastructure. Most of Jason’s research is focused on supporting science- and evidence-based policy and regulation. Jason is a member of the European Federation of Pharmaceutical Industry Associations (Efpia) PIE Task Force, its Governance Team, and chairs its Environmental Risk Assessment Group. Jason also sits on the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) AMR Alliance Working Group for Manufacturing and managing its environmental impacts. Jason holds a Honorary Professorship at the Universities of Warwick and Newcastle. Jason is a member of the SETAC Pharmaceutical Interest Group and sits on the UK Natural Environment Research Council (NERC) Innovation Advisory Board.